Supernus Pharmaceuticals (SUPN) Q4 2019 Earnings

5NovConfirmed
Q1 2019
Q2 2019
Q3 2019
Q4 2019
0.27
0.38
0.5
0.61

Details

Expected EPS
0.59
Actual EPS
0.54
Surprise EPS
-0.05
Surprise Percent
+8.47%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.54 per share for Q4 2019.

0 Comments

Share your thoughts